Calumet Specialty Products Partners scheduled its Q3 2026 earnings for November 6, following Q2 results showing 40.8% revenue growth to $1.45 billion despite an adjusted EPS loss. Investors await impr
Calumet, Inc. announced it will report third-quarter 2026 financial results on November 6, 2026, with a conference call and webcast available for investors.
Calumet Specialty Products Partners announced it will report third-quarter 2026 financial results on November 6, 2026, with a live webcast conference call at 9:00 AM ET.
HC Wainwright lowered Calumet's FY2027 EPS estimate to $0.59 following a quarterly loss, despite 40.8% revenue growth; analysts maintain a Hold rating.
Calumet Specialty Products Partners is set to report Q2 earnings tomorrow, with analysts expecting 6.6% year-on-year revenue growth. Investors will monitor performance against infrastructure peers fol
HC Wainwright forecasts Calumet Specialty Products Partners to earn $0.20 per share in Q1 2027, contrasting with a recent significant earnings miss. Analysts maintain an average 'Hold' rating with a p
Calumet Specialty Products Partners reported Q1 2026 adjusted EBITDA of $50.1 million, driven by strong fuel margins despite facility downtime. The company plans deleveraging and potential monetizatio
Calumet Specialty Products Partners missed Q1 2026 earnings estimates with a $3.64 loss per share despite revenue growth. Operational issues at its Shreveport plant impacted production, while biofuel
Calumet Specialty Products Partners reported $50.1 million adjusted EBITDA for Q1 2026, impacted by Shreveport facility downtime and crude price spikes, while Montana Renewables advanced its MaxSAF 15
Calumet Specialty Products Partners reported Q1 CY2026 sales of $1.03 billion, exceeding Wall Street expectations, though GAAP loss and EBITDA missed consensus due to derivative losses.
ChemBrief